German vaccine authority recommends Imvanex for adults at risk of monkeypox

FILE PHOTO: An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. The company, headquartered in Denmark, is the only one in the world to have approval for a smallpox vaccine called Jynneos in the U.S. and Imvanex in Europe, which is also effective against monkeypox. REUTERS/Lukas Barth


Germany's vaccine advisory committee recommends that people over 18 who have been exposed to or are at increased risk of monkeypox infection receive Bavarian Nordic's Imvanex vaccine, it said on Thursday.

Those at increased risk of monkeypox include men who have sex with multiple male partners and infectious disease lab workers, the committee, known as STIKO, said.